The role of recombinant human DNase in the treatment of patients with cystic fibrosis: many promises, more problems.
Zach
M S
MS
Paediatric Department, University of Graz, Austria.
D003131:Combined Modality Therapy; D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D003851:Deoxyribonucleases / Q000494:pharmacology / Q000627:therapeutic use*; D004363:Drug Utilization; D006801:Humans; D008168:Lung / Q000187:drug effects / Q000503:physiopathology; D011994:Recombinant Proteins / Q000627:therapeutic use; D013183:Sputum / Q000187:drug effects
D011994:Recombinant Proteins; D003851:Deoxyribonucleases